Inflammation and Cancer

This research cluster focuses on the role of inflammation in cardiovascular disease and cancer. Despite its crucial role in protecting the body, inflammation can also be inappropriate and “misplaced” leading to a wide range of chronic conditions such as rheumatoid arthritis, inflammatory bowel disease, asthma, and multiple sclerosis. Inflammation also plays an important role in atherosclerotic cardiovascular disease and cancer. This group will aim at understanding commonalities and differences between cardiovascular disease and cancer and the role that inflammation plays. The CIHR initiative will support the discovery and validation of common biomarkers, therapeutic targets, and resolution of inflammatory mechanisms. The development of prevention and treatment approaches are a key priority (adapted from the CIHR Focused Topics).

Members

Name Primary Affiliation Role
Michael Boffa University of Windsor, Chemistry and Biochemistry Assistant Professor
Dora Cavallo-Medved University of Windsor, Biological Sciences Lecturer/Adjunct Professor
Donna Clinansmith Windsor Regional Hospital, Clinical Trials CRA
James W. Gauld University of Windsor, Chemistry and Biochemistry Associate Professor
Jeff Geml Hotel-Dieu Grace Healthcare, Research Department Manager
Phillip Karpowicz University of Windsor, Biological Sciences Assistant Professor
Krista Naccarato Windsor Regional Hospital, Clinical Trials Business Coordinator, Clinical Trials
Lee Sippel Windsor Regional Hospital, Cancer Program RN – Telemedicine Oncology
Otis Vacratsis University of Windsor, Chemistry and Biochemistry Associate Professor